花斑作为心源性休克的预后标志物
FRENSHOCK是一项2016年4月至10月在法国重症监护病房开展的前瞻性多中心观察性注册研究,共纳入772例心源性休克患者,其中660例(85.5%)在入院时评估了皮肤花斑,约39%存在花斑。花斑组患者需要有创呼吸支持的比例显著更高(50.2% vs 30.1%,p<0.001),需要肾脏替代治疗的比例为19.9% vs 12.4%(p=0.09),需要机械循环支持的比例两组相似。花斑组住院时间更长(19 vs 16天,p=0.033),30天死亡率更高(31% vs 23.3%,p=0.031),1年死亡率也显著更高(54% vs 42%,p=0.003)。入院后24小时内出现花斑的亚组30天预后最差。作者认为花斑作为一种灌注导向的复苏参数,简单且基于临床,可能有助于改善和指导心源性休克患者的即刻目标导向治疗。
要点
- 心源性休克患者入院时约39%存在皮肤花斑,花斑组30天死亡率为31% vs 无花斑组23.3%(p=0.031)。
- 花斑组1年死亡率为54% vs 无花斑组42%(p=0.003),住院时间为19 vs 16天(p=0.033)。
- 花斑组需要有创呼吸支持的比例为50.2% vs 30.1%(p<0.001),需要肾脏替代治疗的比例为19.9% vs 12.4%(p=0.09)。
- 两组需要机械循环支持的比例相似。
- 入院后24小时内出现花斑的亚组30天预后最差。
适用人群与场景
- 法国重症监护病房收治的心源性休克患者,涵盖所有病因,共772例纳入,其中660例在入院时评估了皮肤花斑。
研究设计与关键结果
- FRENSHOCK为前瞻性多中心观察性注册研究,2016年4月至10月在法国重症监护病房开展,纳入772例心源性休克患者(平均年龄65.7 ± 14.9岁;男性71.5%),其中660例(85.5%)在入院时评估了皮肤花斑,约39%存在花斑。
- 花斑组需要有创呼吸支持的比例显著更高(50.2% vs 30.1%,p < 0.001),需要肾脏替代治疗的比例为19.9% vs 12.4%(p = 0.09),需要机械循环支持的比例两组相似。
- 花斑组住院时间更长(19 vs 16天,p = 0.033),30天死亡率更高(31% vs 23.3%,p = 0.031),1年死亡率也显著更高(54% vs 42%,p = 0.003)。
- 入院后24小时内出现花斑的亚组30天预后最差。
证据类型、等级与局限
- 证据类型:前瞻性多中心观察性注册研究(FRENSHOCK)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,花斑作为一种灌注导向的复苏参数,简单且基于临床,可能有助于改善和指导心源性休克患者的即刻目标导向治疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIMS: Impact of skin mottling has been poorly studied in patients admitted for cardiogenic shock. This study aimed to address this issue and identify determinants of 30-day and 1-year mortality in a large cardiogenic shock cohort of all etiologies.
METHODS AND RESULTS: FRENSHOCK is a prospective multicenter observational registry conducted in French critical care units between April and October, 2016. Among the 772 enrolled patients (mean age 65.7 ± 14.9 years; 71.5% male), 660 had skin mottling assessed at admission (85.5%) with almost 39% of patients in cardiogenic shock presenting mottling. The need for invasive respiratory support was significantly higher in patients with mottling (50.2% vs. 30.1%, p < 0.001) and likewise for the need for renal replacement therapy (19.9% vs. 12.4%, p = 0.09). However, the need for mechanical circulatory support was similar in both groups. Patients with mottling at admission presented a higher length of stay (19 vs. 16 days, p = 0.033), a higher 30-day mortality rate (31% vs. 23.3%, p = 0.031), and also showed significantly higher mortality at 1-year (54% vs. 42%, p = 0.003). The subgroup of patients in whom mottling appeared during the first 24 h after admission had the worst prognosis at 30 days.
CONCLUSION: Skin mottling at admission in patients with cardiogenic shock was statistically associated with prolonged length of stay and poor outcomes. As a perfusion-targeted resuscitation parameter, mottling is a simple, clinical-based approach and may thus help to improve and guide immediate goal-directed therapy to improve cardiogenic shock patients' outcomes.
参考来源
- Merdji H, Bataille V, Curtiaud A, et al. Mottling as a prognosis marker in cardiogenic shock. Ann Intensive Care. 2023. PMID: 37672139. doi:10.1186/s13613-023-01175-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。